Back to search

Bromocriptine in the Treatment of Parkinsonism

Data up to Jan 2025

Published1979
Citations35
References57

Total Citations Per Year

Abstract

References (57)

Advances in biochemical psychopharmacology

1970 • 1,186 citations

"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY

1976 • 651 citations

Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons

1973 • 394 citations

Metoclopramide

1976 • 319 citations

Bromocriptine in Parkinsonism

1974 • 311 citations

STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND <scp>l</scp>‐DOPA

1976 • 209 citations

Treatment of Parkinson's Disease with Aporphines

1976 • 167 citations

Evidence for a new type of dopamine receptor stimulating agent

1971 • 152 citations

TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE

1974 • 137 citations

LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE

1978 • 135 citations

Hypotension Caused by L-Dopa

1970 • 128 citations

Treatment of Parkinson's Disease with Bromocriptine

1976 • 123 citations

Effects of bromocriptine on central dopaminergic receptors

1976 • 98 citations

Effects of dopamine agonists in tardive dyskinesia

1977 • 94 citations

BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM

1976 • 90 citations

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.

1976 • 85 citations

On the mechanism of action of cyclic AMP and its role in synaptic transmission.

1972 • 76 citations

IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINE

1975 • 73 citations

ORAL L‐DOPA TREATMENT OF PARKINSONISM

1970 • 73 citations

Monoamine fluorescence histochemistry of human post mortem brain

1973 • 72 citations

Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.

1974 • 72 citations

Studies on the antiparkinsonian efficacy of lergotrile

1975 • 70 citations

Neuroleptic antagonism of dyskinetic phenomena

1975 • 66 citations

Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover

1976 • 58 citations

Studies with bromocriptine Part 1. “On‐off” phenomena

1976 • 58 citations

Effects on the Central Nervous System

1978 • 54 citations

The antiparkinsonian efficacy of bromocriptine

1976 • 53 citations

Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.

1975 • 52 citations

Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.

1978 • 48 citations

Cardiovascular actions of bromocriptine.

1978 • 44 citations

Studies with bromocriptine

1976 • 43 citations

Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.

1978 • 43 citations

THE CARDIOVASCULAR EFFECTS OF BROMOCRIPTINE IN PARKINSONISM

1976 • 42 citations

Binding Interactions of Ergot Alkaloids with Monoaminergic Receptors in the Brain

1978 • 42 citations

EFFECT of CB 154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSS-OVER TRIAL

1976 • 40 citations

Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines

1975 • 37 citations

Digital Vasospasm with Bromocriptine

1976 • 37 citations

Radioisotope scanning in inflammatory muscle disease

1976 • 30 citations

The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents

1977 • 30 citations

BROMOCRIPTINE VERSUS PLACEBO IN LEVODOPA TREATED PATIENTS WITH PARKINSON'S DISEASE

2009 • 27 citations

RE-EXAMINATION OF HUMAN CALCITONIN RADIOIMMUNOASSAY

1978 • 27 citations

Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.

1977 • 27 citations

Absence of uterine neoplasia in patients on bromocriptine.

1977 • 26 citations

Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

1977 • 25 citations

Studies with bromocriptine Part 2. Double‐blind comparison with levodopa in idiopathic parkinsonism

1976 • 25 citations

Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.

1978 • 25 citations

Apomorphine as an antagonist of the dopamine response from the nucleus accumbens

1976 • 21 citations

The Action of L(-)-Dopa on Baroreflexes in Parkinsonism

1972 • 19 citations

Neurotransmitter systems and their clinical disorders

1978 • 16 citations

Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.

1977 • 16 citations

Bromocriptin and methylergometrine : Pharmacological approach of the mechanism of their central effects

1977 • 15 citations

A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat

1976 • 15 citations

BROMOCRIPTINE IN THE TREATMENT OF ADVANCED PARKINSONISM

2009 • 15 citations

Brain Dopamine Turnover and the Relief of Parkinsonism

1977 • 13 citations

Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.

1977 • 13 citations

The role of dopamine as a neurotransmittor in the central and the autonomic nervous system.

1978 • 9 citations

Levodopa and pressor amine sensitivity in parkinsonism

1972 • 4 citations

Cited By (0)

Loading...